Evidence of frequent recombination among human adenoviruses

Journal of General Virology

Volumn 89, Issue 2, 2008, Pages 380-388

  Lukashev, Alexander N ^a,b   Ivanova, Olga E ^b   Eremeeva, Tatiana P ^b   Iggo, Richard D ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b CHUMAKOV INSTITUTE OF POLIOMYELITIS AND VIRAL ENCEPHALITIDES   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; E1A PROTEIN; VIRUS PROTEIN; CAPSID PROTEIN; HEXON CAPSID PROTEIN, ADENOVIRUS; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENETIC SIMILARITY; GENOME ANALYSIS; GENOMIC INSTABILITY; HEP 2 CELL; HUMAN; HUMAN ADENOVIRUS; HUMAN CELL; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEROTYPE; SPECIES COMPARISON; STRAIN DIFFERENCE; VIRAL GENETICS; VIRUS GENOME; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS RECOMBINATION; VIRUS STRAIN; VIRUS TYPING; CLASSIFICATION; GENE ORDER; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENETICS; MOLECULAR GENETICS; PHYLOGENY; VIRUS GENE; VIRUS INFECTION;

ADENOVIRIDAE; HUMAN ADENOVIRUS;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; CAPSID PROTEINS; DNA, VIRAL; GENE ORDER; GENES, VIRAL; GENOME, VIRAL; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECOMBINATION, GENETIC; VARIATION (GENETICS); VIRAL PROTEINS;

EID: 41649116518     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83057-0     Document Type: Article

References (42)

1. Adhikary, A. K., Banik, U., Numaga, J., Suzuki, E., Inada, T. & Okabe, N. (2004). Heterogeneity of the fibre sequence in subgenus C adenoviruses. J Clin Pathol 57, 612-617.
2. Adrian, T., Schafer, G., Cooney, M. K., Fox, J. P. & Wigand, R. (1988). Persistent enteral infections with adenovirus types 1 and 2 in infants: no evidence of reinfection. Epidemiol Infect 101, 503-509.
3. Bailey, A. & Mautner, V. (1994). Phylogetietic relationships among adenovirus serotypes. Virology 205, 438-452.
4. Boursnell, M. E. & Mautner, V. (1981). Recombination in adenovirus: crossover sites in intertypic recombinants are located in regions of homology. Virology 112, 198-209.
5. Breyer, B., Jiang, W., Chang, H., Zhou, L., Paul, R., Feng, T. & He, T. C. (2001). Adenoviral vector-mediated gene transfer for human gene therapy. Curr Gene Ther 1, 149-162.
6. Casas, I., Avellon, A., Mosquera, M., Jabado, O., Echevarria, J. E., Campos, R. H., Rewers, M., Perez-Brena, P., Lipkin, W. I. & Palacios, G. (2005). Molecular identification of adenoviruses in clinical samples by analyzing a partial hexon genomic region. J Clin Microbiol 43, 6176-6182.
7. Chroboczek J., Bieber, F. & Jacrot, B. (1992). The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 186, 280-285.
8. Crawford-Miksza, L. K. & Schnurr, D. P. (1996). Adenovirus serotype evolution is driven by illegitimate recombination in the hypervariable regions of the hexon protein. Virology 224, 357-367.
9. Ebner, K., Pinsker, W. & Lion, T. (2005). Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic and clinical implications. J Virol 79, 12635-12642.
10. Fallaux, F. J., Kranenburg, O., Cramer, S. J., Houweling, A., Van Ormondt, H, Hoeben, R. C. & Van Der Eb, A. J. (1996). Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 7, 215-222.
11. Fallaux, F. J., Bout, A., van der Velde, I., van den Wollenberg, D. J., Hehir, K. M, Keegan, J., Auger, C., Cramer, S. J., van Ormondt, H. & other authors (1998). New helper cells and matched early region 1 - deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 9, 1909-1917.
12. Felsenstein, J. (1989). PHYLIP: phylogeny inference package (version 3.2). Cladistics 5, 164-166.
13. Gagnebin, J., Brunori, M., Otter, M., Juillerat-Jeanneret, L., Monnier, P. & Iggo, R. (1999). A photosensitising adenovirus for photodynamic therapy. Gene Ther 6, 1742-1750.
14. Garnett C. T., Erdman, D., Xu, W. & Gooding, L. R. (2002). Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol 76, 10608-10616.
15. Grodzicker, T., Anderson, C., Sharp, P. A. & Sambrook, J. (1974). Conditional lethal mutants of adenovirus 2-simian virus 40 hybrids. I. Host range mutants of Ad2 + ND1. J Virol 13, 1237-1244.
16. Hall, T. A. (1999). BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41, 95-98.
17. Hay, A. J., Gregory, V., Douglas, A. R. & Lin, Y. P. (2001). The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 356, 1801-1870.
18. Hehir, K. M., Armentano, D., Cardoza, L. M., Choquette, T. L., Berthelette, P. B., White, G. A., Couture, L. A., Everton, M. B., Keegan, J. & other authors (1996). Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J Virol 70, 8459-8467.
19. Horwitz, M. S. (2001). Adenoviruses. In Fields Virology, 4th edn, vol. 2, pp. 2301-2326. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
20. Kangasniemi, L., Kiviluoto, T., Kanerva, A., Raki, M., Ranki, T., Sarkioja, M., Wu, H., Marini, F., Hockerstedt, K. & other authors (2006). Infectivity-enhanced adenoviruses deliver efficacy in clinical samples and orthotopic models of disseminated gastric cancer. Clin Cancer Res 12, 3137-3144.
21. Lauer, K. P., Llorente, I., Blair, E., Seto, J., Krasnov, V., Purkayastha, A., Ditty, S. E., Hadfield, T. L., Buck C. & other authors (2004). Natural variation among human adenoviruses: genome sequence and annotation of human adenovirus serotype 1. J Gen Virol 85, 2615-2625.
22. Lin, B, Wang, Z., Vora, G. J, Thornton, J. A., Schnur, J. M., Thach, D. C., Blaney, K. M., Ligler, A. G., Malanoski, A. P. & other authors (2006). Broad-spectrum respiratory tract pathogen identification using resequencing DNA microarrays. Genome Res 16, 527-535.
23. Lochmuller, H., Jani, A., Huard, J., Prescott, S., Simoneau, M., Massie, B., Karpati, G. & Acsadi, G. (1994). Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 +delta E3) during multiple passages in 293 cells. Hum Gene Ther 5, 1485-1491
24. Lukashev, A. N. (2005). Role of recombination in evolution of enteroviruses. Rev Med Virol 15, 157-167.
25. Lukashev, A. N., Lashkevich, V. A., Ivanova, O. E, Koroleva, G. A., Hinkkanen, A. E. & Ilonen, J. (2005). Recombination in circulating enterovirus B: independent evolution of structural and non-structural genome regions. J Gen Virol 86, 3281-3290.
26. Madisch, I., Harste, G., Pommer, H. & Heim, A. (2005). Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy. J Virol 79, 15263-45276.
27. Martin, D. P., Williamson, C. & Posada, D. (2005). RDP2: recombination detection and analysis from sequence alignments. Bioinformatics 21, 260-262.
28. Mautner, V. & Boursnell, M. E. (1983). Recombination in adenovirus: DNA sequence analysis of crossover sites in intertypic recombinants. Virology, 131, 1-10.
29. Mautner, V., Williams, J., Sambrook J., Sharp, P. A. & Grodzicker, T. (1975). The location of the genes coding for hexon and fiber proteins in adenovirus DNA. Cell 5, 93-99.
30. Ni, S., Bernt K., Gaggar, A., Li, Z. Y., Kiem, H. P. & Lieber, A. (2005). Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons. Hum Gene Ther 16, 664-677.
31. Oberste, M. S., Maher, K. & Pallansch, M. A. (2004). Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes. J Virol 78, 855-867.
32. Palmer, D. H., Mautner, V. & Kerr, D. J. (2002). Clinical experience with adenovirus in cancer therapy. Curr Opin Mol Ther 4, 423-434.
33. Roberts, R. J., Akusjaervi, G., Alestroem, P., Gelinas, R. E., Gingeras, T. R., Sciaky, D. & Pettersson, U. (1986). A consensus sequence for the adenovirus-2 genome. In Adenovirus DNA, pp. 1-51. Edited by W. Doerfler. Boston: Martinus Nijhoff.
34. Salminen, M. O., Carr, J. K., Burke, D. S. & McCutchan, F. E. (1995). Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 11, 1423-1425.
35. Segerman, A., Arnberg, N., Erikson, A., Lindman, K. & Wadell, G. (2003). There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses. J Virol 77, 1157-1162.
36. Shenk, T. E. (2001). Adenoviridae: the viruses and their replication. In Fields Virology, 4th edn, vol. 2, pp. 2265-2300. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott, Williams & Wilkins.
37. Stoff-Khalili, M. A., Rivera, A. A., Glasgow, J. N., Le, L. P. Stoff, A., Everts, M., Tsuruta, Y., Kawakami, Y., Bauerschmitz, G. J. & other authors (2005). A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy. Gene Ther 12, 1696-1706.
38. Thompson, J. D., Higgins D. G. & Gibson, T. J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673-4680.
39. Thompson, J. D., Gibson, T., Plewniak, F., Jeanmougin, F. & Higgins, D. (1997). The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25, 4876-4882.
40. Wadell, G., Hammarskjold, M. L., Winberg, G., Varsanyi, T. M. & Sundell, G. (1980). Genetic variability of adenoviruses. Ann N Y Acad Sci 354, 16-42.
41. Williams, J., Grodzicker, T., Sharp, P. & Sambrook, J. (1975). Adenovirus recombination: physical mapping of crossover events. Cell 4, 113-119.
42. Young, L. S., Searle, P. F., Onion, D. & Mautner, V. (2006). Viral gene therapy strategies: from basic science to clinical application. J Pathol 208, 299-318.